Small Molecules

30 Aug 2007 Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
30 Aug 2007 FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
29 Aug 2007 Merck Announces FDA Acceptance of NDA for CORDAPTIVE(TM) (ER niacin/laropiprant), Formerly Known as MK-0524A, an Investigational Lipid-Modifier
29 Aug 2007 Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
29 Aug 2007 FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI
29 Aug 2007 EPIX Pharmaceuticals Achieves Milestone iEPIX Pharmaceuticals Achieves Milestone in Collaboration with Cystic Fibrosis Foundation Therapeuticsn Collaboration with Cystic Fibrosis Foundation Therapeutics
29 Aug 2007 MGI PHARMA Signs Agreement for Rights to Novel Treatment for Thrombocytopenia
29 Aug 2007 Allergan and Exonhit's first collaboration compound to begin human clinical trials
29 Aug 2007 Compugen Announces Agreement with Teva Covering Splice Variant of MCP1 for Treatment of Chronic Inflammatory Diseases
29 Aug 2007 FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI
29 Aug 2007 EPIX Pharmaceuticals Achieves Milestone in Collaboration with Cystic Fibrosis Foundation Therapeutics
29 Aug 2007 CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
29 Aug 2007 Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
29 Aug 2007 Medicis and Hyperion Therapeutics Announce Strategic Collaboration
29 Aug 2007 Indevus Announces Submission of New Drug Application
29 Aug 2007 Kythera Biopharmaceuticals initiates Phase II study of its adypolitic agent for reduction of submental fat
28 Aug 2007 Biomira initiates Phase 1 trial of PX-478 in patients with advanced metastatic cancers
28 Aug 2007 Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
28 Aug 2007 TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
28 Aug 2007 Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
27 Aug 2007 Rasilez(R) receives EU approval, the first major innovation in high blood pressure treatment for more than a decade
27 Aug 2007 Neurochem announces results from tramiprosate (ALZHEMED(TM)) North American Phase III clinical trial
25 Aug 2007 Approval of an additional dosage and administration for secondary eradication of Helicobacter pylori for proton pump inhibitors in Japan
24 Aug 2007 Aricept(R) Receives Approval for Additional Efficacy and Dosage
24 Aug 2007 GlaxoSmithKline Accelerates Review of Exelixis' XL880

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top